Literature DB >> 29891884

Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation.

Whitney L Wooderchak-Donahue1,2, Peter Johnson1, Jamie McDonald2,3, Francine Blei4, Alejandro Berenstein5, Michelle Sorscher5, Jennifer Mayer6, Angela E Scheuerle7, Tracey Lewis1, J Fredrik Grimmer8, Gresham T Richter9, Marcie A Steeves10, Angela E Lin10, David A Stevenson11, Pinar Bayrak-Toydemir12,13.   

Abstract

RASA1-related disorders are vascular malformation syndromes characterized by hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM), arteriovenous fistulas (AVF), or Parkes Weber syndrome. The number of cases reported is relatively small; and while the main clinical features are CMs and AVMs/AVFs, the broader phenotypic spectrum caused by variants in the RASA1 gene is still being defined. Here, we report the clinical and molecular findings in 69 unrelated cases with a RASA1 variant identified at ARUP Laboratories. Sanger sequencing and multiplex ligation-dependent probe amplification were primarily used to evaluate RASA1. Several atypical cases were evaluated using next-generation sequencing (NGS) and array-comparative genomic hybridization (aCGH). Sixty individuals had a deleterious RASA1 variant of which 29 were novel. Nine individuals had a variant of uncertain significance. Five large RASA1 deletions were detected, giving an overall deletion/duplication rate of 8.3% (5/60) among positive cases. Most (75.4%) individuals with a RASA1 variant had CMs, and 44.9% had an AVM/AVF. Clinical findings in several cases expand the RASA1 phenotype. Our data suggest that screening for large RASA1 deletions and duplications in this disorder is important and suggest that NGS multi-gene panel testing is beneficial for the molecular diagnosis of cases with complex vascular phenotypes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891884      PMCID: PMC6138627          DOI: 10.1038/s41431-018-0196-1

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Mapping short DNA sequencing reads and calling variants using mapping quality scores.

Authors:  Heng Li; Jue Ruan; Richard Durbin
Journal:  Genome Res       Date:  2008-08-19       Impact factor: 9.043

3.  EPHB4 Mutation Implicated in Capillary Malformation-Arteriovenous Malformation Syndrome: A Case Report.

Authors:  JiaDe Yu; Jenna L Streicher; Livija Medne; Ian D Krantz; Albert C Yan
Journal:  Pediatr Dermatol       Date:  2017-07-21       Impact factor: 1.588

Review 4.  ras GTPase activating protein: signal transmitter and signal terminator.

Authors:  F McCormick
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

5.  Prenatal diagnosis of cerebral and extracerebral high-flow lesions revealing familial capillary malformation-arteriovenous malformation (CM-AVM) syndrome.

Authors:  A Lacalm; A Fichez; B Broussin; C Abel; D Lacombe; L Guibaud
Journal:  Ultrasound Obstet Gynecol       Date:  2018-03       Impact factor: 7.299

6.  Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis.

Authors:  M G Sayed; A F Ahmed; J R Ringold; M E Anderson; J L Bair; F A Mitros; H T Lynch; S T Tinley; G M Petersen; F M Giardiello; B Vogelstein; J R Howe
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

7.  MutationTaster2: mutation prediction for the deep-sequencing age.

Authors:  Jana Marie Schwarz; David N Cooper; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2014-04       Impact factor: 28.547

8.  RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.

Authors:  Colleen F Macmurdo; Whitney Wooderchak-Donahue; Pinar Bayrak-Toydemir; Jenny Le; Matthew B Wallenstein; Carlos Milla; Joyce M C Teng; Jonathan A Bernstein; David A Stevenson
Journal:  Am J Med Genet A       Date:  2016-03-11       Impact factor: 2.802

9.  A novel association between RASA1 mutations and spinal arteriovenous anomalies.

Authors:  R Thiex; J B Mulliken; N Revencu; L M Boon; P E Burrows; M Cordisco; Y Dwight; E R Smith; M Vikkula; D B Orbach
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

10.  Capillary malformation-arteriovenous malformation: a clinical review of 45 patients.

Authors:  Margarita Larralde; María Eugenia Abad; Paula Carolina Luna; Mariana Viktoria Hoffner
Journal:  Int J Dermatol       Date:  2013-10-29       Impact factor: 2.736

View more
  10 in total

Review 1.  Vascular anomalies: clinical perspectives.

Authors:  Joao Guilherme Amaral; Irene Lara-Corrales
Journal:  Pediatr Radiol       Date:  2022-01-05

Review 2.  Genetics of brain arteriovenous malformations and cerebral cavernous malformations.

Authors:  Hiroki Hongo; Satoru Miyawaki; Yu Teranishi; Daiichiro Ishigami; Kenta Ohara; Yu Sakai; Daisuke Shimada; Motoyuki Umekawa; Satoshi Koizumi; Hideaki Ono; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Hum Genet       Date:  2022-07-13       Impact factor: 3.755

3.  An autopsy case of Parkes-Weber syndrome with high-output heart failure: Hemodynamic alterations following treatment for arteriovenous fistulas.

Authors:  Hiroaki Yamamoto; Masanobu Makiuchi; Chieko Itamoto; Hideo Hata
Journal:  J Cardiol Cases       Date:  2022-04-18

Review 4.  Imaging of benign cervicofacial vascular anomalies and associated syndromes.

Authors:  Anthony S Larson; Waleed Brinjikji; Katelyn R Anderson; Megha Tollefson; V Michelle Silvera; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-08-16       Impact factor: 1.764

5.  Comprehensive targeted next-generation sequencing in patients with slow-flow vascular malformations.

Authors:  Akifumi Nozawa; Akihiro Fujino; Shunsuke Yuzuriha; Souichi Suenobu; Aiko Kato; Fumiaki Shimizu; Noriko Aramaki-Hattori; Kanako Kuniyeda; Kazuya Sakaguchi; Hidenori Ohnishi; Yoko Aoki; Michio Ozeki
Journal:  J Hum Genet       Date:  2022-09-29       Impact factor: 3.755

Review 6.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

7.  Unilateral and segmental distribution of facial erythema: is it a real port-wine stain?

Authors:  Qingqing Cen; Yi Sun; Xiaojing Zeng; Yun Liu; Fatao Liu; Hui Chen; Xiaoxi Lin; Ren Cai
Journal:  Hereditas       Date:  2020-07-07       Impact factor: 3.271

8.  Assessing the association of common genetic variants in EPHB4 and RASA1 with phenotype severity in familial cerebral cavernous malformation.

Authors:  Foram Choksi; Shantel Weinsheimer; Jeffrey Nelson; Ludmila Pawlikowska; Christine K Fox; Atif Zafar; Marc C Mabray; Joseph Zabramski; Amy Akers; Blaine L Hart; Leslie Morrison; Charles E McCulloch; Helen Kim
Journal:  Mol Genet Genomic Med       Date:  2021-09-07       Impact factor: 2.183

Review 9.  A Primer on a Comprehensive Genetic Approach to Vascular Anomalies.

Authors:  Alexandra J Borst; Taizo A Nakano; Francine Blei; Denise M Adams; Jessica Duis
Journal:  Front Pediatr       Date:  2020-10-19       Impact factor: 3.418

Review 10.  Role of RASA1 in cancer: A review and update (Review).

Authors:  Yanhua Zhang; Yue Li; Quanyue Wang; Bo Su; Hui Xu; Yang Sun; Pei Sun; Rumeng Li; Xiaochun Peng; Jun Cai
Journal:  Oncol Rep       Date:  2020-10-13       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.